Pieton Thierry 4/A
4/A · Medtronic plc · Filed Mar 10, 2025
Insider Transaction Report
Form 4/AAmended
Pieton Thierry
EVP & Chief Financial Officer
Transactions
- Award
Ordinary Shares
2025-03-03+4,242→ 4,242 total - Award
Stock Option (Right to Buy)
2025-03-03+29,574→ 29,574 totalExercise: $94.30Exp: 2035-03-03→ Ordinary Shares (29,574 underlying) - Award
Ordinary Shares
2025-03-03+26,512→ 30,754 total
Footnotes (3)
- [F1]Form 4 filed 3/5/2025 reported incorrect vesting information for restricted stock units due to an administrative error. The purpose of this amendment is to correct the vesting description to state: Represents restricted stock units that vest 100% on July 29, 2027.
- [F2]Form 4 filed 3/5/2025 reported incorrect pricing information for restricted stock units due to an administrative error. The purpose of this amendment is to reflect that restricted stock units were received as a grant, for no consideration.
- [F3]Form 4 filed 3/5/2025 reported incorrect vesting information for options due to an administrative error. The purpose of this amendment is to correct the vesting description to state: The options are exercisable in four equal annual installments on July 29th of 2025, 2026, 2027 and 2028.